Clinical trials
Phase 3 Kidney Failure, Chronic trials in Italy
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2007 | 3 |
| 2009 | 3 |
| 2012 | 2 |
| 2014 | 1 |
| 2017 | 1 |
| 2022 | 3 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 10 |
| Terminated | 4 |
| Active, not recruiting | 2 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Affymax | 2 |
| Amgen | 1 |
| Astellas Pharma Europe B.V. | 1 |
| Astellas Pharma Global Development, Inc. | 1 |
| Bristol-Myers Squibb | 1 |
| Cara Therapeutics, Inc. | 1 |
| Eli Lilly and Company | 1 |
| Giovanni FM Strippoli, MD | 1 |
| GlaxoSmithKline | 1 |
| Hansa Biopharma AB | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Kidney Failure, Chronic | 17 |
| Renal Insufficiency, Chronic | 9 |
| Anemia | 5 |
| Cardiovascular Diseases | 2 |
| Kidney Diseases | 2 |
| Atherosclerosis | 1 |
| Cerebrovascular Disorders | 1 |
| Coronary Artery Disease | 1 |
| Death | 1 |
| Diabetes Mellitus, Type 2 | 1 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.